Why HCP outreach is so important for recruiting patients in rare disease
In rare disease trials, where patients are few and diagnosis is complex, trusted healthcare providers play a critical role in bridging the gap. This blog explores why HCP outreach is a powerful and often overlooked tool for patient recruitment, and how it can drive more qualified referrals and meaningful engagement.
Higher frequency of HCP visits in the US correlates to greater likelihood of clinical trial participation.
In our most recent international survey of patients in Canada, South Africa and the US measuring the impact of healthcare usage, we found the country with the lowest healthcare usage overall and lowest trust in the healthcare system (South Africa) interestingly had the highest likelihood of clinical trial participation. However, when we took a closer […]
Why aren’t doctors telling their patients about clinical trials?
Though patients are interested in clinical research, they aren’t talking about clinical trials. Here’s how CROs and sponsors can continue to tap into patient interest.
FDA Says Clinical Trials Are Too Confusing – Even for Doctors
If doctors and nurses don’t understand basic clinical trial information, why would they refer their patients?
New Tufts Research Explores Barriers to Clinical Trial Recruitment Success
Dwindling physician referrals for clinical trials is just one small piece of a much larger issue.
